Nathan Treybeck – Wells Fargo

Wells Fargo

A Wells Fargo analyst with 1 tracked rating covering 1 distinct ticker has a 1.2-star track record on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

29 days ago

2026-05-06 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 1
Hold: 0
Bearish: 0

Aggregated

43% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 7
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
LMAT	2026-05-06	unknown	$104.00	Aggregated
IRTC	2026-05-01	buy	$180.00	Aggregated
RMD	2026-05-01	unknown	$227.00	Aggregated
PRCT	2026-03-20	buy	$34.00	Aggregated
LMAT	2026-02-26	unknown	$94.00	Aggregated
PRCT	2026-02-26	buy	$34.00	Aggregated
IRTC	2026-02-20	buy	$200.00	Aggregated
RMD	2026-01-30	unknown	$270.00	Aggregated
IRTC	2026-01-13	buy	$225.00	Aggregated
LMAT	2025-11-07	unknown	$93.00	Aggregated
PRCT	2025-11-05	buy	$51.00	Aggregated
PRCTPROCEPT BIOROBOTICS CORP	2025-11-05	unknown	$51.00	Aggregated
RMD	2025-10-13	unknown	$280.00	Aggregated
RMDRESMED INC.	2025-10-13	unknown	$280.00	Aggregated
PRCT	2025-08-07	buy	$58.00	Aggregated
IRTCIRHYTHM TECHNOLOGIES INC	2025-02-21	unknown	$104.00	Aggregated
LMAT	2025-02-13	unknown	$95.00	Aggregated
LMATLEMAITRE VASCULAR INC	2025-02-13	unknown	$95.00	Aggregated
NVRONEVRO CORP	2024-12-11	unknown	$4.00	Aggregated
ITGRINTEGER HOLDINGS CORP	2024-12-03	unknown	$160.00	Aggregated
PRCT	2024-12-03	buy	$112.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
LMAT	4	2026-05-06	Aggregated
IRTC	3	2026-05-01	Aggregated
RMD	3	2026-05-01	Aggregated
PRCT	5	2026-03-20	Aggregated
PRCTPROCEPT BIOROBOTICS CORP	1	2025-11-05	Aggregated
RMDRESMED INC.	1	2025-10-13	Aggregated
IRTCIRHYTHM TECHNOLOGIES INC	1	2025-02-21	Aggregated
LMATLEMAITRE VASCULAR INC	1

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.